🔎 Trials Near Me

Hjem › Multipelt myelom › Florida › Jacksonville

Kliniske studier for Multipelt myelom i Jacksonville, FL

18 studier for Multipelt myelom søker deltakere på steder i og rundt Jacksonville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Rekrutterer
  • Mayo Clinic in Florida, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06630104

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

RekruttererFase 3
  • Mayo Clinic Jacksonville, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07518186

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

RekruttererFase 3
  • Mayo Clinic Jacksonville, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07258511

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

RekruttererFase 1
  • Mayo Clinic in Florida, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06465316

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

RekruttererFase 3
  • Baptist MD Anderson Cancer Center, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

RekruttererFase 2
  • Mayo Clinic in Florida, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06297226

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

RekruttererFase 1
  • Mayo Clinic Florida, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT06375044

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

RekruttererFase 1
  • Mayo Clinic Hospital - Florida, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT05651932

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

RekruttererFase 1/2
  • Research Site, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05850234

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

RekruttererFase 2
  • Mayo Clinic - Florida, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07284758

Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma

RekruttererFase 2
  • Mayo Clinic in Florida, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT05847569

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

RekruttererFase 3
  • Mayo Clinic in Florida, Jacksonville
Alle aldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT05561387

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

RekruttererFase 2
  • Mayo Clinic in Florida, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 20. apr. 2026 · NCT05969860

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

RekruttererFase 1
  • Cancer Specialists, LLC, Jacksonville
Alder 18 og eldre · Alle kjønn · Oppdatert 1. nov. 2023 · NCT03110822

Multipelt myelom-studier i andre byer

Andre studier i Jacksonville

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.